JPRN-UMIN000035827Completed未知
Comparison of clinical significance of novel reactive oxygen species biomarker among new categories of non-ischemic heart failure - Reactive oxygen species in non-ischemic heart failure
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Kumamoto University
- Enrollment
- 201
Study Overview
Brief Summary
DROM measurements can provide important prognostic information for risk stratification in any category of NIHF.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Do not meet diagnostic criteria for non-ischemic heart failure Severe valvular disease Active infection diseases History of malignancy End stage of chronic kidney diseases
Investigators
Similar Trials
Completed
Not Applicable
Novel Objective Digital Biomarkers for Assessing Sub-clinical Mood Disturbances in the Singaporean PopulationMoodNCT06115590Institute for Human Development and Potential (IHDP), Singapore120
Recruiting
Not Applicable
Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIAIschemic StrokeTIANCT06495073Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)125
Unknown
Not Applicable
Hemathologic and Imagiologic Predictors of Stroke During Carotid Endarterectomy With Regional AnesthesiaCarotid StenosisCarotid EndarterectomyNCT04327492Universidade do Porto272
Recruiting
Not Applicable
Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial FibrillationAtrial FibrillationNCT02741349Saint Antoine University Hospital825
Recruiting
Not Applicable
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung CancerAdenocarcinoma of LungNode LungNCT05665504H. Lee Moffitt Cancer Center and Research Institute250